Rapid Detection Tuberculosis Test - HEV IgG/IgM Test Cassette

Short Description:

The TB IgG/IgM Rapid Test Device (Whole Blood/Serum/Plasma) is a sandwich lateral flow chromatographic immunoassay for the qualitative detection of antibodies (IgG and IgM) anti-Mycobacterium Tuberculosis (M.TB) in human serum or plasma. It is intended to be used as a screening test and as an aid in the diagnosis of infection with M. TB. Any reactive specimen with the TB IgG/ IgM Rapid Test device must be confirmed with alternative testing method(s) and clinical findings.


Product Detail

Product Tags

In the complex world of infectious diseases, timely and accurate diagnostics are key to effective treatment and control. At QL Biotech, we understand the critical impact of swift diagnosis on tuberculosis (TB) management and control efforts. This understanding has driven us to develop and refine our Tuberculosis IgG/IgM Rapid Test Device, an advanced diagnostic tool designed to meet the urgent needs of healthcare providers and patients alike. The core of our TB diagnostic solution lies in the innovative application of the lateral flow chromatographic immunoassay, a technology that harnesses the double antigen–sandwich technique to provide prompt and reliable results. This device is specifically crafted to detect the presence of IgG and IgM antibodies to Mycobacterium tuberculosis, the causative agent of TB, in human serum, plasma, or whole blood samples. The presence of these antibodies typically indicates a current or past infection, providing essential information for accurate diagnosis and treatment. Our test device is characterized by its user-friendly design, requiring only a minimal sample volume to conduct the test. The process involves applying the sample along with the assay buffer to the cassette, initiating the flow of the sample through the reactive pad which contains conjugated antigens specific to TB. If IgG or IgM antibodies are present, they will bind to these conjugates. The test and control lines on the device will then display color changes, visually confirming the presence or absence of TB antibodies within approximately 15 minutes. This rapid turnaround time is crucial for early intervention and management of tuberculosis, offering a significant advantage over traditional diagnostic methods that may take days to provide results.

PRINCIPLE

The TB Antibody Rapid Test device is a lateral flow chromatographic immunoassay based on the principle of the double antigen–sandwich technique. The test cassette consists of: 1) a burgundy colored conjugate pad containing M.TB antigens conjugated with colloid gold (M.TB conjugates)and rabbit IgG‐gold conjugates, 2) a nitrocellulose membrane strip containing a test band (T band) and a control band (C band). The T band is pre‐coated with non‐conjugated M.TB antigens, and the C band is pre‐coated with goat anti‐rabbit IgG. When an adequate volume of test specimen is dispensed into the sample well of the cassette, the specimen migrates by capillary action across the cassette. The antibodies: either the IgG, the IgM to M. TB if present in the specimen will bind to the M.TB conjugates. The immunocomplex is then captured on the membrane by the pre‐coated M.TB antigens, forming a burgundy colored T band, indicating a M.TB Ab positive test result. Absence of the T band suggests a negative result. The test contains an internal control (C band) which should exhibit a burgundy colored band of the immunocomplex of goat anti‐rabbit IgG/rabbit IgG‐gold conjugate regardless the presence of any antibodies to M.TB. Otherwise, the test result is invalid and the specimen must be retested with another device.


Product Detail

          • Brand: QL

            Specimens: :Plasma/ Serum/ Whole Blood

            Reading time:1 minutes.

            Pack:25 T

            STORAGE: 2‐30°C

            KIT COMPONENTS

            • Test devices
            • Droppers
            • Buffer
            • Package insert

 

  • TEST PRINCIPLE

        • The TB IgG/IgM Rapid Test Device (Whole Blood/Serum/Plasma) is a lateral flow chromatographic immunoassay based on the principle of the double antigen–sandwich technique. The test cassette consists of: 1) a burgundy colored conjugate pad containing M.TB antigens conjugated with colloid gold (M.TB conjugates) and rabbit IgG‐gold conjugates, 2) a nitrocellulose membrane strip containing a test band (T band) and a control band (C band). The T band is pre‐coated with non‐conjugated M.TB antigens, and the C band is pre‐coated with goat anti‐rabbit IgG.

          When an adequate volume of test specimen is dispensed into the sample well of the cassette, the specimen migrates by capillary action across the cassette. The antibodies: either the IgG, the IgM to M. TB if present in the specimen will bind to the M.TB conjugates. The immunocomplex is then captured on the membrane by the pre‐coated M.TB antigens, forming a burgundy colored T band, indicating a M.TB Ab positive test result.

          Absence of the T band suggests a negative result. The test contains an internal control (C band) which should exhibit a burgundy colored band of the immunocomplex of goat anti‐rabbit IgG/rabbit IgG‐gold conjugate regardless the presence of any antibodies to M.TB. Otherwise, the test result is invalid and the specimen must be retested with another device.


        ASSAY PROCEDURE

        1. Bring the specimen and test components to room temperature. Place the test device  on a clean, flat surface. 
        2. Be sure to label the device with specimen’s ID number. 
        3. Fill the plastic dropper with the specimen. Holding the dropper vertically, dispense 2  drops (about 80 µL) of specimen into the sample well making sure that there are no  air bubbles. Then add 1 drop of buffer into the sample well. Set up timer. 
        4. Results can be read in 10 minutes. Positive results can be visible in as short as 1  minute. Don’t read result after 10 minutes. To avoid confusion, discard the test  device after interpreting the result.

        •  
        • INTERPRETATION OF ASSAY RESULT



          IgG Positive:* The colored line in the control line region (C) appears and a colored line appears in test line region IgG. The result is positive for Tuberculosis specific-IgG antibodies and is indicative of secondary Tuberculosis infection.

          IgM Positive:* The colored line in the control line region (C) appears and a colored line appears in test line region IgM. The result is positive for Tuberculosis specific-IgM and is probably indicative of primary Tuberculosis infection.

          IgG and IgM Positive:* The colored line in the control line region (C) appears and two colored lines should appear in test line regions IgG and IgM. The color intensities of the lines do not have to match. The result is positive for IgG & IgM antibodies and is indicative of secondary Tuberculosis infection.

          *NOTE: The intensity of the color in the test line region(s) will vary depending on the concentration of Tuberculosis antibodies in the specimen. Therefore, any shade of color in the test line region(s) should be considered positive.

          NEGATIVE RESULT:

          The colored line in the control line region (C) appears. No line appears in test line regions IgG or IgM.

          INVALID RESULT:

          Control line (C) falls to appear. Insufficient buffer volume or incorrect procedural techniques are the most likely reasons for control line failure. Review the procedure and repeat the procedure with a new test device. If the problem persists, discontinue using the test kit immediately and contact your local distributor.
           



        Leveraging our Tuberculosis IgG/IgM Rapid Test Device, healthcare providers can make informed decisions quickly, enhancing patient care and potentially curbing the spread of tuberculosis. This tool is especially valuable in resource-limited settings where access to sophisticated laboratory facilities may be restricted. By offering a high degree of sensitivity and specificity, our device stands as a cornerstone in the fight against TB, facilitating early detection and treatment which are vital for reducing transmission and improving patient outcomes. At QL Biotech, we are committed to advancing public health through innovative diagnostic solutions. The Tuberculosis IgG/IgM Rapid Test Device exemplifies our dedication to providing reliable, accessible, and easy-to-use diagnostic tools. Through continual research and development, we strive to meet the evolving challenges of infectious disease diagnostics, ensuring that our products remain at the forefront of technology and healthcare needs.

      • Previous:
      • Next: